145 related articles for article (PubMed ID: 17498910)
1. A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma.
Vairaktaris E; Vassiliou S; Nkenke E; Serefoglou Z; Derka S; Tsigris C; Vylliotis A; Yapijakis C; Neukam FW; Patsouris E
Eur J Surg Oncol; 2008 Apr; 34(4):450-5. PubMed ID: 17498910
[TBL] [Abstract][Full Text] [Related]
2. Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer.
Vairaktaris E; Yapijakis C; Vasiliou S; Derka S; Nkenke E; Serefoglou Z; Vorris E; Vylliotis A; Ragos V; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(6B):4095-100. PubMed ID: 18225577
[TBL] [Abstract][Full Text] [Related]
3. A metalloproteinase-13 polymorphism affecting its gene expression is associated with advanced stages of oral cancer.
Vairaktaris E; Yapijakis C; Nkenke E; Serefoglou ZC; Chatzitheofylaktou A; Vassiliou S; Derka S; Vylliotis A; Perrea D; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(6B):4027-30. PubMed ID: 18225566
[TBL] [Abstract][Full Text] [Related]
4. Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinoma.
Vairaktaris E; Yapijakis C; Derka S; Serefoglou Z; Vassiliou S; Nkenke E; Ragos V; Vylliotis A; Spyridonidou S; Tsigris C; Yannopoulos A; Tesseromatis C; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(1A):459-64. PubMed ID: 17352267
[TBL] [Abstract][Full Text] [Related]
5. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
Tu HF; Wu CH; Kao SY; Liu CJ; Liu TY; Lui MT
J Oral Pathol Med; 2007 Aug; 36(7):409-14. PubMed ID: 17617834
[TBL] [Abstract][Full Text] [Related]
6. The interleukin-8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma.
Vairaktaris E; Yapijakis C; Serefoglou Z; Derka S; Vassiliou S; Nkenke E; Vylliotis A; Wiltfang J; Avgoustidis D; Critselis E; Neukam FW; Patsouris E
Eur J Surg Oncol; 2007 May; 33(4):504-7. PubMed ID: 17174061
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer.
Vairaktaris E; Yapijakis C; Serefoglou Z; Vylliotis A; Ries J; Nkenke E; Wiltfang J; Derka S; Vassiliou S; Springer I; Kessler P; Neukam FW
Oral Oncol; 2006 Oct; 42(9):888-92. PubMed ID: 16730474
[TBL] [Abstract][Full Text] [Related]
8. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer.
Vairaktaris E; Yapijakis C; Tsigris C; Vassiliou S; Derka S; Nkenke E; Spyridonidou S; Vylliotis A; Vorris E; Ragos V; Neukam FW; Patsouris E
Acta Oncol; 2007; 46(8):1097-102. PubMed ID: 17851834
[TBL] [Abstract][Full Text] [Related]
9. Association of polymorphisms in Tumor Necrosis Factor Alpha and Beta genes with increased risk for oral cancer.
Yapijakis C; Serefoglou Z; Vylliotis A; Nkenke E; Derka S; Vassiliou S; Avgoustidis D; Neukam FW; Patsouris E; Vairaktaris E
Anticancer Res; 2009 Jun; 29(6):2379-86. PubMed ID: 19528505
[TBL] [Abstract][Full Text] [Related]
10. High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer.
Vairaktaris E; Serefoglou Z; Yapijakis C; Vylliotis A; Nkenke E; Derka S; Vassiliou S; Avgoustidis D; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(4B):2493-8. PubMed ID: 17695544
[TBL] [Abstract][Full Text] [Related]
11. The interleukin-18 -607A/C polymorphism is not associated with risk for oral cancer.
Vairaktaris E; Serefoglou ZC; Yapijakis C; Agapi C; Vassiliou S; Nkenke E; Antonis V; Sofia S; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(6B):4011-4. PubMed ID: 18225563
[TBL] [Abstract][Full Text] [Related]
12. Angiotensinogen polymorphism is associated with risk for malignancy but not for oral cancer.
Vairaktaris E; Yapijakis C; Vylliotis A; Derka S; Vassiliou S; Nkenke E; Serefoglou Z; Ragos V; Critselis E; Avgoustidis D; Neukam F; Patsouris E
Anticancer Res; 2008; 28(3A):1675-9. PubMed ID: 18630525
[TBL] [Abstract][Full Text] [Related]
13. Increased risk for oral cancer is associated with coagulation factor XIII but not with factor XII.
Vairaktaris E; Vassiliou S; Yapijakis C; Spyridonidou S; Vylliotis A; Derka S; Nkenke E; Fourtounis G; Neukam FW; Patsouris E
Oncol Rep; 2007 Dec; 18(6):1537-43. PubMed ID: 17982641
[TBL] [Abstract][Full Text] [Related]
14. A DNA polymorphism of stromal-derived factor-1 is associated with advanced stages of oral cancer.
Vairaktaris E; Vylliotis A; Spyridonodou S; Derka S; Vassiliou S; Nkenke E; Yapijakis C; Serefoglou Z; Neukam FW; Patsouris E
Anticancer Res; 2008; 28(1A):271-5. PubMed ID: 18383856
[TBL] [Abstract][Full Text] [Related]
15. The interleukin-10 (-1082A/G) polymorphism is strongly associated with increased risk for oral squamous cell carcinoma.
Vairaktaris E; Yapijakis C; Serefoglou Z; Derka S; Vassiliou S; Nkenke E; Vylliotis A; Spyridonidou S; Neukam FW; Schlegel KA; Patsouris E
Anticancer Res; 2008; 28(1A):309-14. PubMed ID: 18383862
[TBL] [Abstract][Full Text] [Related]
16. The platelet glycoprotein Ibalpha VNTR polymorphism is associated with risk for oral cancer.
Vairaktaris E; Serefoglou ZC; Yapijakis C; Vassiliou S; Nkenke E; Avgoustidis D; Vylliotis A; Stathopoulos P; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(6B):4121-5. PubMed ID: 18225582
[TBL] [Abstract][Full Text] [Related]
17. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
[TBL] [Abstract][Full Text] [Related]
18. The interleukin-1 beta gene polymorphism +3953 C/T is not associated with risk for oral cancer.
Vairaktaris E; Serefoglou Z; Yapijakis C; Stathopoulos P; Vassiliou S; Derka S; Nkenke E; Vylliotis A; Ragos V; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(6B):3981-6. PubMed ID: 18225559
[TBL] [Abstract][Full Text] [Related]
19. Strong association of interleukin-4 (-590 C/T) polymorphism with increased risk for oral squamous cell carcinoma in Europeans.
Vairaktaris E; Yannopoulos A; Vassiliou S; Serefoglou Z; Vylliotis A; Nkenke E; Critselis E; Avgoustidis D; Yapijakis C; Neukam FW; Patsouris E
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Dec; 104(6):796-802. PubMed ID: 17428692
[TBL] [Abstract][Full Text] [Related]
20. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer.
Yu C; Zhou Y; Miao X; Xiong P; Tan W; Lin D
Cancer Res; 2004 Oct; 64(20):7622-8. PubMed ID: 15492291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
